CAMKMT and neoplasm: KMT abnormalities in the complex tumor microenvironment cause expression mutations of key immune regulators in tumor cells and effector genes in immune cells, which may lead to antigen presentation suppression, loss of immune tolerance, blocked anti-tumor immunity, and negative effects on immunotherapy.